Galantamine

CHEMBL659 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
287.4 g/mol
LogP
1.8
Phase
4

This medication treats the symptoms of Alzheimer's disease by inhibiting the enzyme that breaks down acetylcholine, increasing levels of this memory-related neurotransmitter in the brain. It also sensitizes nicotinic receptors to acetylcholine, which may provide additional cognitive benefit.

Moleküler Ağırlık

287,3500 g/mol

LogP

1,80

TPSA

41,90 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2

InChI

InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1

Molecular Formula

C17H21NO3

HBD / HBA

1 / 4

Döndürülebilir Bağlar

1

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication treats the symptoms of Alzheimer's disease by inhibiting the enzyme that breaks down acetylcholine, increasing levels of this memory-related neurotransmitter in the brain. It also sensitizes nicotinic receptors to acetylcholine, which may provide additional cognitive benefit.

Yes, Galantamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL659. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9651. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.